RT Journal Article
T1 Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet).
A1 Locati, Laura
A1 Cavalieri, Stefano
A1 Dal Maso, Luigino
A1 Busco, Susanna
A1 Anderson, Lesley Ann
A1 Botta, Laura
A1 Bento, Maria Jose
A1 Carulla, Maria
A1 Chirlaque Lopez, Maria Dolores
A1 Fusco, Mario
A1 Guevara, Marcela
A1 Innos, Kaire
A1 Børge Johannesen, Tom
A1 Micallef, Rita
A1 Minicozzi, Pamela
A1 Panato, Chiara
A1 Petrova, Dafina
A1 Rubio-Casadevall, Jordi
A1 Smailyte, Giedre
A1 Francesca Vitale, Maria
A1 Trama, Annalisa
K1 Anaplastic thyroid cancer
K1 Cancer registries
K1 Epidemiology
K1 Incidence
K1 Medullary thyroid cancer
K1 Thyroid cancer
AB Limited information is available on the incidence of rare thyroid cancer (TC) subtypes: anaplastic (ATC) and medullary (MTC). The aim of this study was to describe incidence variations and trends across European countries of all TC subtypes. We used the RARECAREnet database including 80721 TC incident cases in the period 2000-2007 from 77 population-based cancer registries (CRs) in Europe. In the trend analyses, we included 68890 TC cases from 53 CRs with at least 6 years of incidence data in the years 2000-2007. In Europe age-standardised incidence rates (ASR) in women were  The huge increase and heterogeneity between countries of PTC incidence has a small influence on the trends and variations of MTC and ATC in Europe. Large-scale epidemiological and clinical registry-based studies are warranted to increase knowledge about the rarest TC subtypes. This information would be fundamental for the design of new clinical trials and for inference.
PB Elsevier Ltd
YR 2020
FD 2020-04-29
LK http://hdl.handle.net/10668/15636
UL http://hdl.handle.net/10668/15636
LA en
NO Locati L, Cavalieri S, Dal Maso L, Busco S, Anderson LA, Botta L, et al. Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet). Oral Oncol. 2020 Sep;108:104766.
DS RISalud
RD Apr 8, 2025